Inmune Bio (INMB) Other Non Operating Income (2019 - 2025)
Inmune Bio (INMB) posted Other Non Operating Income of $166000.0 for Q1 2025, up 2175.0% sequentially from -$8000.0 in Q1 2024, and up 2175.0% YoY from $7296.7 in Q1 2024.
Inmune Bio (INMB) Other Non Operating Income (2019 - 2025) Analysis & Trends
Inmune Bio has reported Other Non Operating Income for 5 years, with the latest figure at $166000.0 in Q1 2025.
- Quarterly Other Non Operating Income rose 2175.0% year-over-year to $166000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $154574.0 (up 69.75% YoY) and the FY2024 annual result came in at $553000.0, up 307.12% from the prior year.
- Other Non Operating Income climbed to $166000.0 in Q1 2025 per INMB's latest filing, from -$8000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $166000.0 in Q1 2025 and troughed at -$8000.0 in Q1 2021.
- A 3-year average of $50000.0 and a median of -$8000.0 in 2021 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2021 and 2025: Other Non Operating Income tumbled 136.36% in 2021, then soared 2175.0% in 2025.
- Over 3 years, Other Non Operating Income stood at -$8000.0 in 2021, then changed by 0.0% to -$8000.0 in 2024, then jumped by 2175.0% to $166000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $166000.0, -$8000.0, and -$8000.0 for Q1 2025, Q1 2024, and Q1 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Inmune Bio | 61.59 Mn | 43.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 166,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Mar 31, 2021 | -8,000.00 |
| Dec 31, 2020 | 4,574.00 |
| Sep 30, 2020 | 102,484.00 |
| Jun 30, 2020 | -395.00 |
| Mar 31, 2020 | 22,000.00 |
| Dec 31, 2019 | 14,086.00 |
| Sep 30, 2019 | 17,220.00 |
| Jun 30, 2019 | 36,340.00 |
| Mar 31, 2019 | 10,042.00 |